Showing results (1231-1240 of 1,538) with videos related to
Sort By:
Pageof 154
Clinical Genitourinary Cancer|August 21, 2025
Clinical and Pathological Predictors for Occult Lymph Node Involvement in Patients With Clinical Node-Negative Bladder Cancer Undergoing Radical CystectomySalvador Jaime-Casas, Miguel Zugman, Regina Barragan-Carrillo, et al.Frontiers in Oncology|October 23, 2025
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinomaSalvador Jaime-Casas, Regina Barragan-Carrillo, Miguel Zugman, et al.Clinical Genitourinary Cancer|July 26, 2023
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell CarcinomaNazli Dizman, Ameish Govindarajan, Zeynep B Zengin, et al.BJU International|April 2, 2020
Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinomaSumanta K Pal, David F McDermott, Michael B Atkins, et al.The Lancet. Oncology|June 16, 2025
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trialNeeraj Agarwal, Arun A Azad, Joan Carles, et al.Cancer Investigation|October 14, 2022
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey StudyDaniela V Castro, Zeynep B Zengin, Jasnoor Malhotra, et al.European Urology Oncology|August 19, 2025
Development of a Health-related Quality of Life Questionnaire for Patients with Metastatic or Localized Renal Cell CarcinomaCristiane D Bergerot, David Cella, Paulo G Bergerot, et al.European Journal of Human Genetics : EJHG|January 12, 2022
Complementing the phenotypical spectrum of TUBA1A tubulinopathy and its role in early-onset epilepsiesJulian Schröter, Bernt Popp, Heiko Brennenstuhl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate CancerEvan Y Yu, Hongli Li, Celestia S Higano, et al.JAMA Network Open|January 21, 2021
Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With SurvivalShaan Dudani, Guillermo de Velasco, J Connor Wells, et al.Pageof 154